Similarly, we discovered that monocytes (such as HLA DR on CD14+ CD16-monocyte, HLA DR on CD14+ monocyte, and HLA DR on monocyte) were linked to a lower risk of ovarian cancer. Here, CD14 is linked to ovarian carcinoma.